Inhibitors to factor VIII in patients with hemophilia A / Esraa Mahmoud Khaliel Swailam ; Supervised Normein Abdelhalim Kadah , Azza Ibraheim Mostafa , Rania Ismail Magdi
Material type:
- المثبطات للعامل الثامن في المرضى الذين يعانون من الهيموفيليا ا [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2014.Es.I (Browse shelf(Opens below)) | Not for loan | 01010110064191000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.28.M.Sc.2014.Es.I (Browse shelf(Opens below)) | 64191.CD | Not for loan | 01020110064191000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
Cai01.11.28.M.Sc.2014.Em.U Usefulness of serum lipid peroxide as a diagnostic test for hypoxic ischemic encephalopathy in the full-term neonate / | Cai01.11.28.M.Sc.2014.Em.V Vitamin D deficiency in critically Ill Egyptian children / | Cai01.11.28.M.Sc.2014.Em.V Vitamin D deficiency in critically Ill Egyptian children / | Cai01.11.28.M.Sc.2014.Es.I Inhibitors to factor VIII in patients with hemophilia A / | Cai01.11.28.M.Sc.2014.Es.I Inhibitors to factor VIII in patients with hemophilia A / | Cai01.11.28.M.Sc.2014.Fa.S Study of growth differentiation factor 15 level in patients with beta thalassemia major / | Cai01.11.28.M.Sc.2014.Fa.S Study of growth differentiation factor 15 level in patients with beta thalassemia major / |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics
Hemophilia A is X-linked coagulation disorder occurs due to mutation in the gene responsible of Factor VIII production.Providing the deficient factor VIII to the patient (whether plasma derived or synthesized) is a must. Formation of Factor VIII inhibitors one of the most complex side effects of treatment. The present study was conducted on 30 pediatric hemophilic patients, all are males to evaluate risk factor for inhibitors development. Eight patients showed positive factor VIII inhibitors. Treatment of six of them were with increasing the dose of the replacement factor (Factor VIII or Cryo), and three patients needed factor VII to be prepared for surgery and to treat acute bleeding episodes
Issued also as CD
There are no comments on this title.